Tapimmune Inc (TPIVD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TPIVD | AZN | AMGN | GILD | BMY |
| Company | Tapimmune Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 6.2000 | 205.64 | 388.00 | 147.87 | 62.37 |
| High | 6.2600 | 206.30 | 391.29 | 150.77 | 62.89 |
| Low | 6.1800 | 203.34 | 381.89 | 147.80 | 61.98 |
| Latest | 6.1800 | 203.73 | 385.67 | 150.06 | 62.32 |
| Change | +0.0200 | -4.72 | -2.49 | +1.11 | -0.05 |
| % Change | +0.32% | -2.26% | -0.64% | +0.75% | -0.08% |
| Volume | 4,500 | 1,429,538 | 1,816,064 | 3,262,623 | 8,352,759 |
| 20-Day Average Volume | 16,565 | 2,492,347 | 2,982,760 | 7,670,573 | 13,566,403 |
| Previous Close | 6.1600 | 208.45 | 388.16 | 148.95 | 62.37 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 6.4078 | 200.07 | 372.25 | 149.67 | 60.21 |
| 20-Day Raw Stochastic | 56.50% | 70.44% | 85.65% | 56.94% | 93.63% |
| 20-Day Relative Strength | 49.66 | 58.33 | 62.61 | 59.36 | 67.44 |
| Weighted Alpha | -31.38 | +40.47 | +29.39 | +38.21 | +17.61 |
| Today's Opinion | N/A | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | N/A | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | N/A | 88% Buy | 100% Buy | 100% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.68% since 10/05/16 | -0.40% since 02/23/26 | +1.10% since 02/23/26 | +0.01% since 02/23/26 | +1.84% since 02/23/26 |
| Low | 6.1000 on 10/11/16 | 202.64 on 02/26/26 | 374.25 on 02/26/26 | 143.09 on 02/26/26 | 60.65 on 02/26/26 |
| High | 6.6900 on 10/06/16 | 209.93 on 02/27/26 | 391.14 on 03/02/26 | 150.77 on 03/02/26 | 62.88 on 03/02/26 |
| 1-Month | |||||
| %Chg | +7.29% since 09/12/16 | +8.34% since 02/02/26 | +11.29% since 02/02/26 | +4.87% since 02/02/26 | +11.61% since 02/02/26 |
| Low | 4.9200 on 09/15/16 | 183.63 on 02/03/26 | 338.59 on 02/03/26 | 142.03 on 02/03/26 | 55.49 on 02/03/26 |
| High | 7.1500 on 09/27/16 | 212.71 on 02/18/26 | 391.14 on 03/02/26 | 157.29 on 02/11/26 | 62.88 on 03/02/26 |
| 3-Month | |||||
| %Chg | +7.29% since 07/12/16 | +13.18% since 12/02/25 | +13.37% since 12/02/25 | +20.93% since 12/02/25 | +29.28% since 12/02/25 |
| Low | 4.8000 on 07/19/16 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 49.42 on 12/03/25 |
| High | 7.1500 on 09/27/16 | 212.71 on 02/18/26 | 391.14 on 03/02/26 | 157.29 on 02/11/26 | 62.88 on 03/02/26 |
| 6-Month | |||||
| %Chg | -19.53% since 04/12/16 | +27.27% since 09/02/25 | +33.70% since 09/02/25 | +32.95% since 09/02/25 | +31.58% since 09/02/25 |
| Low | 4.8000 on 07/19/16 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 9.1200 on 05/03/16 | 212.71 on 02/18/26 | 391.14 on 03/02/26 | 157.29 on 02/11/26 | 62.88 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 51,590 | 323,286,752 | 209,244,640 | 184,909,664 | 127,014,880 |
| Shares Outstanding, K | 8,380 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -34,070,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | N/A | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | N/A | 2,326,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | -1.19 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 11/21/16 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.73 | 17.76 | 18.28 | 10.14 |